Concepedia

David Vaughan

DV

Statistics

Publications

12

Citations

466

H-Index

11

Active since

1970

Affiliations

Bayer (Canada)(Current)

Queen's Hospital

Brighton and Sussex Medical School

Cork University Hospital

University College London

David Vaughan is an author at Bayer (Canada) specializing in pharmacy, infectious diseases, and antimicrobial pharmacotherapy.

ORCID

Publications per year

1970–2025

12

Publications

12

A 1-Year Community-Based Health Economic Study of Ciprofloxacin vs Usual Antibiotic Treatment in Acute Exacerbations of Chronic Bronchitis

Ronald F. Grossman, Jayanti Mukherjee, David Vaughan et al. · CHEST Journal · 1998 · 147 citations

, , +12

Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension

Anita Shah, Ming-Chung Liu, David Vaughan et al. · Journal of Antimicrobial Chemotherapy · 1999 · 47 citations · Full text

, , +17

Economic Evaluation of Ciprofloxacin Compared with Usual Antibacterial Care for the Treatment of Acute Exacerbations of Chronic Bronchitis in Patients Followed for 1 Year

George W. Torrance, Valery Walker, Ronald F. Grossman et al. · PharmacoEconomics · 1999 · 42 citations

, , +12

Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study

Christina D. Orrú, David Vaughan, Nirosen Vijiaratnam et al. · The Lancet Neurology · 2025 · 39 citations · Full text

, , +17

Reduced Requirement for Antibiotic Therapy Targeting Gram-Negative Organisms in Febrile, Neutropenic Patients with Cancer Who Are Receiving Antibacterial Chemoprophylaxis with Oral Quinolones

Eric J. Bow, R. Loewen, David Vaughan · Clinical Infectious Diseases · 1995 · 37 citations

, , +17

1–5 of 12